
GMReis was granted FDA 510(k) clearance to market the VersaLock 3.5 mm Tibial Plateau Plating System.
This latest clearance further strengthens the VersaLock Trauma Platform, providing surgeons with anatomically designed titanium implants featuring ±15° variable-angle locking technology and 3.5 mm dynamic compression for the treatment of tibial plateau fractures, osteotomies, and nonunions.
The company’s FDA-cleared trauma plating portfolios cover virtually every major anatomical region, including:
- Foot & Ankle
- Tibial Plateau
- Proximal & Distal Femur
- Hand & Wrist
- Forearm
- Elbow
- Distal & Proximal Humerus
- Clavicle
- Scapula
The VersaLock platform reflects GMReis’ commitment to delivering innovative fixation technologies that combine anatomical design, advanced locking performance, and procedural versatility to meet the evolving needs of orthopedic trauma surgeons worldwide.
Source: GMReis
GMReis was granted FDA 510(k) clearance to market the VersaLock 3.5 mm Tibial Plateau Plating System.
This latest clearance further strengthens the VersaLock Trauma Platform, providing surgeons with anatomically designed titanium implants featuring ±15° variable-angle locking technology and 3.5 mm dynamic compression for the treatment of...
GMReis was granted FDA 510(k) clearance to market the VersaLock 3.5 mm Tibial Plateau Plating System.
This latest clearance further strengthens the VersaLock Trauma Platform, providing surgeons with anatomically designed titanium implants featuring ±15° variable-angle locking technology and 3.5 mm dynamic compression for the treatment of tibial plateau fractures, osteotomies, and nonunions.
The company’s FDA-cleared trauma plating portfolios cover virtually every major anatomical region, including:
- Foot & Ankle
- Tibial Plateau
- Proximal & Distal Femur
- Hand & Wrist
- Forearm
- Elbow
- Distal & Proximal Humerus
- Clavicle
- Scapula
The VersaLock platform reflects GMReis’ commitment to delivering innovative fixation technologies that combine anatomical design, advanced locking performance, and procedural versatility to meet the evolving needs of orthopedic trauma surgeons worldwide.
Source: GMReis
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.





